Recent advances in throughput and accuracy mean that the Oxford Nanopore Technologies PromethiON platform is a now a viable solution for genome sequencing. Much of the validation of bioinformatic tools for this long-read data has focussed on calling germline variants (including structural variants). Somatic variants are outnumbered many-fold by germline variants and their detection is further complicated by the effects of tumour purity/subclonality. Here, we evaluate the extent to which Nanopore sequencing enables detection and analysis of somatic variation. We do this through sequencing tumour and germline genomes for a patient with diffuse B-cell lymphoma and comparing results with 150 bp short-read sequencing of the same samples. Calling...
Targeted sequencing has the advantage of providing pinpointed DNA information, while costs and data-...
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding ...
Somatic mutation calling from next-generation sequencing data remains a challenge due to the difficu...
Recent advances in throughput and accuracy mean that the Oxford Nanopore Technologies PromethiON pla...
Whole-genome sequencing (WGS) is becoming widely used in clinical medicine in diagnostic contexts an...
Introduction: Whole-genome sequencing using nanopore technologies can uncover structural variants, w...
Technological innovation and increased affordability have contributed to the widespread adoption of ...
Despite improvements in genomics technology, the detection of structural variants (SVs) from short-r...
Nanopore sequencing is a recent technology that allows direct real-time sequencing of DNA/RNA molecu...
Technological innovation and increased affordability have contributed to the widespread adoption of ...
Structural variants (SVs) are genomic rearrangements that involve at least 50 nucleotides and are kn...
Cancer development and progression is driven by genetic alterations. These alterations include somat...
Structural variations (SV), a hallmark of genomic instability in cancer, include insertions, deletio...
Cancer, which affects hundreds of thousands of people worldwide every year and costs billions in tre...
Next generation sequencing is extensively applied to catalogue somatic mutations in cancer, in resea...
Targeted sequencing has the advantage of providing pinpointed DNA information, while costs and data-...
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding ...
Somatic mutation calling from next-generation sequencing data remains a challenge due to the difficu...
Recent advances in throughput and accuracy mean that the Oxford Nanopore Technologies PromethiON pla...
Whole-genome sequencing (WGS) is becoming widely used in clinical medicine in diagnostic contexts an...
Introduction: Whole-genome sequencing using nanopore technologies can uncover structural variants, w...
Technological innovation and increased affordability have contributed to the widespread adoption of ...
Despite improvements in genomics technology, the detection of structural variants (SVs) from short-r...
Nanopore sequencing is a recent technology that allows direct real-time sequencing of DNA/RNA molecu...
Technological innovation and increased affordability have contributed to the widespread adoption of ...
Structural variants (SVs) are genomic rearrangements that involve at least 50 nucleotides and are kn...
Cancer development and progression is driven by genetic alterations. These alterations include somat...
Structural variations (SV), a hallmark of genomic instability in cancer, include insertions, deletio...
Cancer, which affects hundreds of thousands of people worldwide every year and costs billions in tre...
Next generation sequencing is extensively applied to catalogue somatic mutations in cancer, in resea...
Targeted sequencing has the advantage of providing pinpointed DNA information, while costs and data-...
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding ...
Somatic mutation calling from next-generation sequencing data remains a challenge due to the difficu...